industry
Popular up and coming topics, concerns, and products in the health and wellness industry.
United States In-Vitro Diagnostics Market Size and Forecast 2025–2033. AI-Generated.
The United States In-Vitro Diagnostics (IVD) market is entering a transformative period driven by advanced molecular technologies, rising chronic disease prevalence, and continued health reforms supporting early and accurate diagnosis. According to Renub Research, the U.S. IVD market size is estimated at US$ 42.71 billion in 2024 and projected to reach US$ 65.01 billion by 2033, reflecting steady growth supported by innovation and increased adoption across healthcare settings. From 2024 to 2030, the market is expected to grow at a 4.78% CAGR, underscoring the indispensable role of diagnostics in modern medicine.
By Janine Root about a month ago in Longevity
Saudi Arabia In-Vitro Diagnostics Market Size and Forecast 2025–2033. AI-Generated.
The Saudi Arabia in-vitro diagnostics (IVD) market is entering a dynamic phase of growth, fueled by rapid advancements in healthcare, expanding diagnostic capabilities, and increasing demand for early and precise disease detection. According to Renub Research, the Saudi Arabian IVD market is projected to reach US$ 1.68 billion by 2033, up from US$ 1.15 billion in 2024, marking a steady 4.30% CAGR between 2025 and 2033.
By Marthan Sirabout a month ago in Longevity
Telemedicine Market Size and Forecast 2025–2033. AI-Generated.
Telemedicine is no longer an emerging technology—it is becoming the backbone of modern healthcare delivery. According to Renub Research, the global telemedicine market is expected to reach US$ 618.34 billion by 2033, rising dramatically from US$ 83.23 billion in 2024, with a powerful CAGR of 24.96% during 2025–2033. This extraordinary rise reflects the accelerating global shift toward digital healthcare, powered by better connectivity, remote monitoring tools, and the growing demand for accessible, cost-effective medical services.
By Aaina Oberoiabout a month ago in Longevity
Protein Ingredients Market Size and Forecast 2025–2033. AI-Generated.
According to Renub Research, the global protein ingredients market was valued at US$ 50.31 billion in 2024 and is projected to exceed US$ 89.21 billion by 2033, growing at a CAGR of 6.57% from 2025 to 2033. This remarkable rise is fueled by global shifts toward high-protein diets, expanding uses across food, beverages, clinical nutrition, and supplements, and the accelerating popularity of plant-based alternatives. As consumers embrace healthier lifestyles and demand cleaner labels, protein ingredients sourced from plants, animals, and microbial processes are transforming modern food systems.
By Renub Researchabout a month ago in Longevity
Global Liquid Biopsy Market Size & Forecast 2025–2033. AI-Generated.
The global liquid biopsy market is entering one of its most transformative growth phases ever recorded. According to Renub Research, the market is set to scale from US$ 4.29 billion in 2024 to an impressive US$ 15.46 billion by 2033, expanding at a vigorous CAGR of 15.30% during 2025–2033. This rapid expansion reflects unprecedented advancements in biomarker analysis, non-invasive cancer diagnostics, next-generation sequencing technologies, and the escalating demand for precision medicine worldwide.
By Renub Researchabout a month ago in Longevity
Saudi Arabia Teleradiology Market Size and Forecast 2025–2033. AI-Generated.
The Saudi Arabia Teleradiology Market is witnessing one of the fastest adoption curves within the Kingdom’s healthcare sector. According to Renub Research, the market is expected to reach US$ 263.93 million by 2033, rising from US$ 100.46 million in 2024, with an impressive CAGR of 11.33% from 2025 to 2033. This growth reflects a transformative shift in how medical imaging is delivered, accessed, and interpreted in Saudi Arabia—ushering in an era where distance no longer limits diagnostic excellence.
By jaiklin Fanandishabout a month ago in Longevity
Japan Age-Related Macular Degeneration (AMD) Market Size and Forecast 2025–2033. AI-Generated.
Japan is stepping into a crucial decade in its fight against Age-Related Macular Degeneration (AMD), a leading cause of vision loss among older adults. According to Renub Research, the Japan Age-Related Macular Degeneration (AMD) Market is projected to reach US$ 897.79 million by 2033, rising from US$ 526.46 million in 2024, reflecting a CAGR of 6.11% from 2025 to 2033. As the nation with one of the highest proportions of elderly citizens globally, Japan faces a growing health challenge that is reshaping its pharmaceutical landscape, healthcare priorities, and diagnostic infrastructure.
By jaiklin Fanandishabout a month ago in Longevity
Japan’s Orthopedic Prosthetics Market Set for Robust Growth Through 2033. AI-Generated.
The Japan Orthopedic Prosthetics Market is expected to reach US$ 163.04 million by 2033, rising from US$ 104.65 million in 2024, according to Renub Research. This steady expansion reflects a CAGR of 5.05% from 2025 to 2033, positioning Japan as one of Asia’s most promising markets for advanced orthopedic prosthetic technologies.
By jaiklin Fanandishabout a month ago in Longevity
United States Narcolepsy Drugs Market Size and Forecast 2025–2033. AI-Generated.
The United States Narcolepsy Drugs Market is stepping into a significant growth phase, driven by rising diagnosis rates, enhanced clinical awareness, and rapid advancements in pharmaceutical innovation. According to Renub Research, the market is projected to reach US$ 2,233.56 million by 2033, up from US$ 1,128.57 million in 2024, representing an impressive CAGR of 7.88% between 2025 and 2033.
By Aaina Oberoiabout a month ago in Longevity
Mexico Microcarrier Market Size and Forecast 2025–2033. AI-Generated.
Mexico Microcarrier Market Overview The Mexico Microcarrier Market is poised for significant expansion as the nation accelerates its investment in biotechnology, biomanufacturing, and cell-based therapeutic development. According to Renub Research, the Mexico Microcarrier Market is expected to reach US$ 77.65 million by 2033, rising from US$ 39.96 million in 2024, and advancing at a CAGR of 7.66% between 2025 and 2033.
By Aaina Oberoiabout a month ago in Longevity
